Galapagos and Gilead Soldier On After Inflammatory Disease Flops
Clinical and regulatory setbacks have left the star biotech duo Gilead and Galapagos smarting and…
04/03/2021 - 4 minutes
Gilead
Galapagos’ Arthritis Drug Approved in EU and Japan Amid US Rejection
The recent EU and Japan approvals of the rheumatoid arthritis drug filgotinib contrast with the…
05/10/2020 - 5 minutes
Remdesivir Becomes the First Covid-19 Treatment Approved in Europe
Remdesivir has received a one-year conditional marketing authorization from the European Commission due to the…
08/07/2020 - 3 minutes
Gilead Pays Billions for Access to Galapagos’ Pipeline
Gilead has launched a 10-year collaboration with the Belgo-Dutch biotech Galapagos, paying at least €4.5B…
15/07/2019 - 2 minutes
Belgian and US Biotechs Team up to Reduce CAR T Side Effects
The diagnostics company Biocartis is collaborating with Kite Pharma to monitor the progress of CAR…
03/06/2019 - 3 minutes
Austrian Biopharma Reaches First HIV Vaccine Milestone
Hookipa Pharma has reached its first milestone in a partnership deal with US-based CAR T…
03/01/2019 - 2 minutes
Galapagos and Gilead Launch the Fifth New Trial for Filgotinib this Year
With the addition of uveitis, Galapagos and Gilead are raising to 10 the number of…
05/07/2017 - 1 minute
Dual HIV Therapy: GSK and Gilead Battle over Whose Drug is the Best
GSK announced Phase III results for dolutegravir, which could reduce triple HIV therapy down to…
14/02/2017 - 2 minutes
Galapagos gets another Milestone Payment from Gilead
Galapagos is starting a new PhaseIIb/III clinical trial for ulcerative colitis that has triggered a €9.4M…
09/12/2016 - 2 minutes
Galapagos Hangs On: Filgotinib enters Phase III for Rheumatoid Arthritis
After losing AbbVie as a partner, Galapagos has pressed on with Gilead in the development…
25/08/2016 - 2 minutes
While working on its HIV Cure, Gilead gives Europe an ‘HIV Vaccine’
Despite progress in HIV treatments and towards an HIV cure, the infection rate has risen…
24/08/2016 - 2 minutes
Gilead licenses Danish Bispecific antibodies for the next HIV Cure
As an add-on to their previously secretive partnership, Genmab is now licensing its bispecific antibodies for…
15/08/2016 - 3 minutes
